Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jon Richards
Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein Gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Autologous Heat-Shock Protein Vaccines
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
Frontiers in Immunology
Allergy
Immunology
Heat Shock Protein Peptide Complex-96 Vaccination for Newly Diagnosed Glioblastoma: A Phase I, Single-Arm Trial
JCI insight
Medicine
Endoplasmic Reticulum Heat Shock Protein Gp96/Grp94 Is a Pro-Oncogenic Chaperone, Not a Tumor Suppressor
Hepatology
Medicine
Hepatology
Treatment of Unresectable Stage IV Metastatic Melanoma With Aviscumine After Anti-Neoplastic Treatment Failure: A Phase II, Multi-Centre Study
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
Journal of Immunology Research
Medicine
Allergy
Immunology
Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial
Clinical Cancer Research
Cancer Research
Oncology
Secretory Heat Shock Protein - Gp96-Ig Chaperoned Her-2/New Vaccines
